Company Active LTD

Company profile

Agplus Diagnostics Ltd

UK company 06994240, incorporated on 19 August 2009.

Home | AgPlus Diagnostics

AgPlus Diagnostics offer point of care testing solutions, test development services & manufacturing to businesses across the USA and Europe.

Company number
06994240
Incorporated
19 Aug 2009
Companies House status
Active

Company identity

Founded / incorporated
19 August 2009

Company number 06994240

Verify at Companies House
Legal name
AGPLUS DIAGNOSTICS LTD
Company type
Private Limited Company
Region
London
Registered address
66 LINCOLN'S INN FIELDS
LONDON
WC2A 3LH
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Agplus Diagnostics Ltd
CRN 06994240
2
Direct and ultimate controller Active LTD

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

16 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

11 Aug
2026

Dissolution Application Strike Off Company

Dissolution

DS01 | Transaction MzUzODA1NTkyOWFkaXF6a2N4

Published 11 Aug 2026 18:57

02 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

19 Aug
2009

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2017
Funded years
2017, 2020
Age at first award
7 years

Projects

2020 Collaborative R&D Lead participant

Development of AgPlus rapid electrochemical immunoassays for COVID-19

1 Sep 2020 to 28 Feb 2021

Awarded
£174,845
Total cost £174,845

SARS-CoV-2 or COVID-19 is virus that is currently spreading throughout the world. Relatively little is understood about the virus but we are learning fast and it is clear that we need to have good diagnosis to support quarantine and treatment. What is known is that the virus has a serial interval of 4 days and 1-3% of the population may be pre-symptomatic...

2020 Feasibility Studies Lead participant

AgPlus Electrochemical COVID-19 Diagnostic Assay

1 Jul 2020 to 31 Dec 2020

Awarded
£49,498
Total cost £49,498

SARS-CoV-2 or COVID-19 is currently spreading throughout the world. Little is understood about the virus but we are learning fast and it is clear that we need to have good, accurate diagnosis to support quarantine and treatment. What is known is that the virus has a serial interval of 4 days and 1-3% of the population may be pre-symptomatic but still tran...

2017 Collaborative R&D Lead participant

Quality Control Test for a Carbon Electrode in a Point-of-Care Diagnostic Test Cartridge

1 Jun 2017 to 31 Mar 2018

Awarded
£44,006
Total cost £62,865

AgPlus Diagnostics produces medical test devices that can be used by a doctor to give patients information on their health in less than 10 minutes during a single doctor’s appointment. Our medical device is used by inserting a test cartridge into a handheld reader that performs the medical test using AgPlus’s unique signal detection chemistry. This is cal...

Product types

Collaborative R&D Feasibility Studies